1Gibb AP, Tribuddharat C, Moore RA, et al. Nosocomial outbreak of carbapenem-resistant Psedomonas aeruginosa with a new bla (IMP)allele, bla(IMP-7). Antimicrob Agents Chemother, 2002, 46: 255-258.
2Yah J, Ko W, Wu J. Identification of a plasmid encoding SHV-12,TEM-1 and a variant of IMP-2 metallo-beta-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae,Antimicrob Agents Chemother,2001,45:2368-2371.
3Laraki N, Galleni M, Tham,, I, et al. Structure of In31, a bla(IMP)-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual anay d gene cassettes.Antimicrob Agents Chemother, 1999, 43: 890-901.
4Laura L, Riccio ML, Mazzariol A, et al. Cloning and Characterization of bla ( VIM ), a new integron-borne metallo-beta-lactamases gene from a Pseudomonas aeruginosa clinical isolate.Antimicrob Agents Chemother. 1999.43 : 1584-1589.
5Cornaglia G, Mazzariol A, Lauretti L, et al. Hospital outbreak of cadmpenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamases. Clin Infect Dis, 2000,31:1119-1125.
6Tsakris A, Pournaras S, Woodford N, et al. Outbreak d infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol, 2000.38: 1290-1292.
7Poirel L, Naas T, Nicolas D, et al. Characterization d VIM-2, a carbapanem-hydrolyzing metallo-beta-lactamase and its plasmid-and integron-borne gene from a Psedomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000.44: 891-897.
8Yah J, Hsueh P, Ko W, et al. Metallo-beta-lactamase in clinical Psedumonas isolates in Taiwan and identification d VIM-3, a novel variant of VIM-2 enzyme. Antimicrob Agents Chemother, 2001,45 :2224-2228.
9Yum JH, Yi K, Lee H, et al. Molecular characterization of metallobeta-lactamase-producing Acinetobacter bsumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla (VIM-2) gene cassettes. J Antimicrob Chemother,2002, 49: 837-840.
10Bou G, Oliver A, Martinez-Beltran J. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother, 2000, 44:1556-1561.
